What does a natural medicine CRO like MedGence do?

MedGence provides end-to-end research and development for plant-derived ingredients: active ingredient screening, potency evaluation by origin and season, analytical method establishment, process studies, toxicity, in vitro, animal and clinical studies, natural formulation research and contract manufacturing of active ingredients and finished products.

Can one partner take my botanical project from lab research to commercial supply?

Yes. Our own pilot plant and collaborative factories are directly managed by our technical team, so validated study results transfer smoothly into OEM/CDMO production of extracts and finished dosage forms.

Which analytical techniques are used to establish quality standards?

Depending on the product, methods include high-performance thin-layer chromatography (HPTLC) identification, high-performance liquid chromatography (HPLC), gas chromatography (GC) and chromatographic fingerprinting.

How is my formula and process know-how protected?

We work on an entrusted contract research and manufacturing model under non-disclosure, so your product information, formulas and process parameters are not disclosed and your competitive advantage is preserved.

Which dosage forms can MedGence develop and manufacture?

Active ingredients can be supplied as concentrated liquids, powders, pastes and volatile oils. Finished products include oral liquids, capsules, softgels, tablets, soluble powders and granules.

Do you support clinical studies for new drug applications?

Yes. We arrange small-group human trials for dietary supplements as well as Phase I, II, III and IV clinical studies to help clients obtain the data required for a new drug application (NDA).

ODM Contract Development And Manufacturing Organization Manufacturer & Supplier

Validated Solutions Portfolio

Featured CDMO Research & Clinical Pipeline Services

Direct laboratory-to-production transfer supported by proprietary scientific pipelines and validated regulatory protocols.

ODM Clinic study Phase1 - Phase 4 Manufacturer, Suppliers

Phase I to Phase IV GCP compliant clinical trials, bio-equivalence evaluations, and human pharmacokinetic documentation.

View Service Details

In vivo pharmacodynamic and pharmacokinetic assays across standardized animal disease models with toxicological metrics.

View Service Details

China Establishment of analysis methods of active ingredients Supplier, Suppliers

Quantitative HPLC, GC-MS, HPTLC, and chromatographic fingerprint identification method development and method validation.

View Service Details

China Screening of the active ingredients of plants Manufacturer, Manufacturers

High-throughput screening of secondary plant metabolites, active alkaloids, polyphenols, and bioactive polysaccharides.

View Service Details

OEM In Vitro Test /Research Service Manufacturers, Suppliers

High-precision cellular toxicity, receptor binding, anti-inflammatory, and metabolic bio-assays on target cell lineages.

View Service Details

ODM Study and evaluation of the potency of the botanical active ingredients

Systematic origin, harvest season, and anatomical matrix profiling to isolate peak active potency for cost-optimized yield.

View Service Details

Botanical Active Ingredient Screening Pipeline

Comprehensive phytochemical discovery matrices bridging legacy ethnopharmacology with modern therapeutic standards.

View Service Details

Origin and Seasonal Botanical Evaluation Platform

Origin-specific botanical fingerprinting guaranteeing regulatory traceability and raw chemical stability.

View Service Details

14+

Years of Botanical R&D Rigor

300+

Full-Time Analytical Scientists

83

Modernized Classic TCM Formulations

400+

Single Herb Analytical Standards

Industrial Strategy

China Supply Chain Integration: The Scalable CDMO Advantage

In botanical medicine and phytochemical active development, combining raw agro-origin traceability with high-throughput manufacturing infrastructure represents the ultimate competitive barrier. MedGence (Yineng Pharma) provides global brands with seamless continuity from field assays to bulk cGMP output.

Direct Agro-Origin Integration

By controlling multi-regional botanical cultivation bases across Hunan, Guangxi, and Guizhou, our supply chain eliminates market volatility, establishes harvest time predictability, and ensures maximum secondary metabolite concentration prior to extraction.

Advanced Continuous Pilot Facilities

Equipped with closed-loop multi-stage counter-current extraction units, resin column adsorption systems, and industrial lyophilization plants, our facilities effortlessly scale batches from kilograms to metric tons without active denaturing.

Total Cost-to-Market Economics

Integrating chemical research, formulation engineering, toxicological documentation, and finished dosage conversion under one organizational roof reduces development turnaround cycles by up to 42% compared to multi-vendor pipelines.

Global Regulatory Assurance

Localized Support & Stringent International Compliance

Overcoming jurisdictional regulatory hurdles is central to pharmaceutical contract development. We construct standardized documentation dossiers fully harmonized with multi-national authorities.

US FDA cGMP & NDIN Readiness

Complete analytical chemistry suites, heavy metal limit tests via ICP-MS, residual solvent analysis (USP <467>), and New Dietary Ingredient Notification (NDIN) dossier generation for rapid North American market commercialization.

EMA Herbal Monograph Alignment

Well-established traditional use dossiers, contaminant screening adhering to European Pharmacopoeia (Ph. Eur.) criteria (including polycyclic aromatic hydrocarbons and mycotoxins), and THMPD registration support.

NMPA Hospital Preparations

Unmatched authority inside China with 56 successful hospital preparation registrations and direct technological partnerships with Grade 3A TCM hospitals, unlocking rapid domestic market entry routes.

Full IP Segregation & Security

Every commercial ODM or CDMO initiative operates under strict dual-jurisdiction non-disclosure protocols, ensuring proprietary compound identities, extraction yields, and formula compositions remain 100% customer-owned.

Procurement Dynamics

Addressing Global Corporate Sourcing & Procurement Pain Points

Pharmaceutical and nutraceutical category leaders require more than raw bulk powder; they require verifiable pharmacological reproducibility, validated assay methodologies, and supply resilience.

Mitigating Batch Variations

Natural raw ingredients suffer from harvest-to-harvest variance. Our scientific team develops HPLC/GC fingerprint standardization models, eliminating active degradation and standardizing chemical profiles within narrow ±2.0% thresholds across all delivered lots.

Compressing R&D Lead Times

Transferring an early-stage target active directly into our established in vitro assay pipelines and rodent disease models shortcuts exploratory time by up to six months, providing tangible safety and efficacy proof before major clinical capital allocation.

Full Supply Chain De-risking

Direct supply contracts with Chinese farming co-ops protect against geopolitical trade friction and speculative raw crop inflation, offering multi-year price locks and uninterrupted volume delivery guarantees.

Future Perspectives

Emerging CDMO Trends: Artificial Intelligence & Green Chemistry

The contract research and manufacturing sector is undergoing rapid paradigm shifts. We combine computational biology with clean extraction processes to set next-generation industry standards.

AI-Assisted Molecular Docking

By deploying machine-learning algorithms against chemical databases containing hundreds of thousands of research batches, we model ligand-receptor interactions in silico, accelerating active target prediction before physical trials commence.

Supercritical Fluid & Green Solvents

Eliminating toxic petrochemical solvents, our facilities scale carbon dioxide (SFE-CO2) supercritical fluid extraction and deep eutectic solvents (DES), yielding pure botanical extracts with virtually zero environmental impact.

Multi-Target Synergy Elucidation

Transitioning from single-molecule drugs to botanical synergy formulas, our high-dimensional metabolomics track how multiple phytochemical components interact on human metabolic and immune signaling pathways simultaneously.

Versatile Implementations

End-Market Specialized Application Scenarios

Our collaborative ecosystem adapts scientific deliverables directly to the technical formats demanded by global retail, clinical, and aesthetic sectors.

Nutraceuticals & Functional Foods

Bio-enhanced microencapsulated extracts, soluble drink powder granules, liquid elixirs, and customized softgels formulated to retain volatile compounds without artificial stabilizers or off-flavor profiles.

Clinical Botanical Pharmaceuticals

NDA-focused API development, verified pharmacokinetic profiling, dose escalation matrices, and full clinical Phase I through IV trial management compliant with global GCP standards.

Cosmeceuticals & Dermal Health

Cell-proven anti-glycation, transdermal anti-inflammatory peptides, natural antioxidant oils, and skin-barrier restorative complexes tested for non-irritancy and clinical cutaneous efficacy.

Technical Clarifications

Frequently Asked Questions on Contract Manufacturing & R&D

Clear, unvarnished insight into project onboarding, manufacturing compliance, IP safety, and validation timelines.

What is the typical timeframe required to develop a validated botanical analytical assay?

Depending on target compound structural complexity and reference standard availability, analytical method establishment using HPLC, GC, or HPTLC fingerprinting generally requires 4 to 8 weeks. This process encompasses specificity validation, linearity, precision, repeatability, and system suitability tests in full accordance with ICH Q2(R1) guidelines.

How does MedGence handle customer formulation confidentiality and IP governance?

Client projects are ring-fenced within physically separated pilot isolation lines and encrypted laboratory databases. Full non-disclosure agreements (NDAs) govern every interaction, and all patent filings, intellectual rights, and proprietary process parameters derived throughout the research program remain 100% the unencumbered property of the contracting client.

Can you scale experimental laboratory yields up to commercial mass supply?

Yes. Our internal scale-up workflow bridges standard lab benchwork with automated 1,000L to 5,000L multi-functional extraction tanks and industrial spray dry towers. By verifying yield loss metrics at the intermediate pilot tier, we ensure seamless transition into multi-ton cGMP finished production without potency deviation.

What support is offered for human clinical trials and international regulatory applications?

We provide turn-key clinical study solutions. This includes small-scale, placebo-controlled human efficacy trials for dietary supplements (supporting EU EFSA or US FTC commercial claims) as well as Phase I–IV clinical study management for clinical NDA files in direct cooperation with accredited hospital review boards.

Commercial Execution

Procure Verified CDMO Capabilities & Contracted Batches

Select from established research methodologies or request custom-tailored laboratory pilot evaluations.

Phase I to Phase IV GCP compliant clinical trials, bio-equivalence evaluations, and human pharmacokinetic documentation.

View Service Details

In vivo pharmacodynamic and pharmacokinetic assays across standardized animal disease models with toxicological metrics.

View Service Details

Quantitative HPLC, GC-MS, HPTLC, and chromatographic fingerprint identification method development and method validation.

View Service Details

High-throughput screening of secondary plant metabolites, active alkaloids, polyphenols, and bioactive polysaccharides.

View Service Details

High-precision cellular toxicity, receptor binding, anti-inflammatory, and metabolic bio-assays on target cell lineages.

View Service Details

Systematic origin, harvest season, and anatomical matrix profiling to isolate peak active potency for cost-optimized yield.

View Service Details

Comprehensive phytochemical discovery matrices bridging legacy ethnopharmacology with modern therapeutic standards.

View Service Details

Origin-specific botanical fingerprinting guaranteeing regulatory traceability and raw chemical stability.

View Service Details